SS
MXCT icon

SBI Securities’s MaxCyte MXCT Stock Holding History

SBI Securities’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49 Hold
40
– – ﹤0.01% 3676
2026
Q1 		$28 Hold
40
– – ﹤0.01% 3694
2025
Q4 		$62 Hold
40
– – ﹤0.01% 3536
2025
Q3 		$63 Hold
40
– – ﹤0.01% 3644
2025
Q2 		$87 Buy
40
+10
+33% +$24 ﹤0.01% 3580
2025
Q1 		$82 Buy
+30
New +$118 ﹤0.01% 3509

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

SBI Securities's MXCT Position: Q2 2026 in Review

SBI Securities held its MaxCyte (MXCT) position steady in Q2 2026 at 40 shares worth $49. The position accounts for ﹤0.01% of the portfolio, ranked #3676.

SBI Securities first reported a position in MXCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $87 in Q2 2025. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • SBI Securities held 40 shares of MaxCyte worth $49 as of Q2 2026.
  • SBI Securities left its MaxCyte share count unchanged in Q2 2026.
  • MaxCyte made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3676 holding.
  • SBI Securities first reported a position in MaxCyte in Q1 2025 and has held it in 6 quarters since.
  • SBI Securities's MaxCyte position peaked at $87 in Q2 2025.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.